Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Hall and Anton Simeonov.
Matthew Hall
Connection Strength
2.207
Anton Simeonov
  1. An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19. ACS Pharmacol Transl Sci. 2020 Oct 09; 3(5):997-1007.
    View in: PubMed
    Score: 0.225
  2. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2. Trends Pharmacol Sci. 2020 11; 41(11):815-829.
    View in: PubMed
    Score: 0.224
  3. Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19. ACS Cent Sci. 2020 06 24; 6(6):1009.
    View in: PubMed
    Score: 0.222
  4. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent Sci. 2020 May 27; 6(5):672-683.
    View in: PubMed
    Score: 0.220
  5. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2. J Biol Chem. 2018 08 31; 293(35):13750-13765.
    View in: PubMed
    Score: 0.193
  6. Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays. Sci Rep. 2017 10 06; 7(1):12758.
    View in: PubMed
    Score: 0.184
  7. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs. Pharmacol Rev. 2017 10; 69(4):479-496.
    View in: PubMed
    Score: 0.184
  8. Fluorescence polarization assays in high-throughput screening and drug discovery: a review. Methods Appl Fluoresc. 2016 04 28; 4(2):022001.
    View in: PubMed
    Score: 0.167
  9. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci. 2021 Jun 11; 4(3):1124-1135.
    View in: PubMed
    Score: 0.059
  10. Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics. Sci Rep. 2021 03 24; 11(1):6725.
    View in: PubMed
    Score: 0.059
  11. Biological activity-based modeling identifies antiviral leads against SARS-CoV-2. Nat Biotechnol. 2021 06; 39(6):747-753.
    View in: PubMed
    Score: 0.058
  12. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
    View in: PubMed
    Score: 0.058
  13. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect Dis. 2021 06 11; 7(6):1389-1408.
    View in: PubMed
    Score: 0.057
  14. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. Mol Ther. 2021 02 03; 29(2):873-885.
    View in: PubMed
    Score: 0.057
  15. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018 08; 16(8):e2006134.
    View in: PubMed
    Score: 0.049
  16. Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery. Clin Transl Sci. 2018 09; 11(5):461-470.
    View in: PubMed
    Score: 0.049
  17. A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase. Sci Rep. 2018 06 21; 8(1):9472.
    View in: PubMed
    Score: 0.048
  18. Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors. Bioorg Med Chem. 2018 05 01; 26(8):1727-1739.
    View in: PubMed
    Score: 0.047
  19. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). J Med Chem. 2017 11 22; 60(22):9184-9204.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.